NO157575C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridin-derivater. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridin-derivater.

Info

Publication number
NO157575C
NO157575C NO841341A NO841341A NO157575C NO 157575 C NO157575 C NO 157575C NO 841341 A NO841341 A NO 841341A NO 841341 A NO841341 A NO 841341A NO 157575 C NO157575 C NO 157575C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
dihydropyridine derivatives
analogy procedure
analogy
Prior art date
Application number
NO841341A
Other languages
English (en)
Norwegian (no)
Other versions
NO841341L (no
NO157575B (no
Inventor
Maurice Ward Gittos
Michael Spedding
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO841341L publication Critical patent/NO841341L/no
Publication of NO157575B publication Critical patent/NO157575B/no
Publication of NO157575C publication Critical patent/NO157575C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
NO841341A 1983-04-06 1984-04-05 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridin-derivater. NO157575C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8309284 1983-04-06

Publications (3)

Publication Number Publication Date
NO841341L NO841341L (no) 1984-10-08
NO157575B NO157575B (no) 1988-01-04
NO157575C true NO157575C (no) 1988-04-13

Family

ID=10540692

Family Applications (1)

Application Number Title Priority Date Filing Date
NO841341A NO157575C (no) 1983-04-06 1984-04-05 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridin-derivater.

Country Status (19)

Country Link
US (1) US4529733A (de)
EP (1) EP0124777B1 (de)
JP (1) JPS59193884A (de)
KR (1) KR880002510B1 (de)
AR (1) AR245941A1 (de)
AT (1) ATE23151T1 (de)
AU (1) AU557521B2 (de)
CA (1) CA1262906A (de)
DE (2) DE124777T1 (de)
DK (1) DK162442C (de)
ES (1) ES531254A0 (de)
GR (1) GR81903B (de)
IE (1) IE57182B1 (de)
IL (1) IL71432A (de)
NO (1) NO157575C (de)
NZ (1) NZ207716A (de)
PH (1) PH19451A (de)
PT (1) PT78370B (de)
ZA (1) ZA842456B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO883326L (no) * 1987-08-11 1989-02-13 Bayer Ag Dhp-retard-tilberedning.
US7150616B2 (en) * 2003-12-22 2006-12-19 Kimberly-Clark Worldwide, Inc Die for producing meltblown multicomponent fibers and meltblown nonwoven fabrics
CN114149360B (zh) * 2021-11-25 2024-03-01 天津太平洋化学制药有限公司 一种高纯度尼群地平原料药的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2003146A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
DE2117573C3 (de) * 1971-04-10 1978-07-27 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von unsymmetrischen l,4-Dihydropyridin-3,5dicarbonsäureestern, sowie ihre Verwendung als Arzneimittel
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
AU557521B2 (en) 1986-12-24
NZ207716A (en) 1986-09-10
PT78370B (en) 1986-05-28
IE57182B1 (en) 1992-05-20
KR880002510B1 (ko) 1988-11-26
PT78370A (en) 1984-05-01
ES8505363A1 (es) 1985-05-16
AU2637584A (en) 1984-10-11
PH19451A (en) 1986-04-18
US4529733A (en) 1985-07-16
DE3461086D1 (en) 1986-12-04
EP0124777B1 (de) 1986-10-29
NO841341L (no) 1984-10-08
DK162442B (da) 1991-10-28
IL71432A0 (en) 1984-07-31
ZA842456B (en) 1984-11-28
AR245941A1 (es) 1994-03-30
ES531254A0 (es) 1985-05-16
GR81903B (de) 1984-12-12
DK179984A (da) 1984-10-07
DK162442C (da) 1992-03-23
DK179984D0 (da) 1984-04-05
NO157575B (no) 1988-01-04
CA1262906C (en) 1989-11-14
DE124777T1 (de) 1985-06-05
JPS59193884A (ja) 1984-11-02
JPH0465073B2 (de) 1992-10-16
IL71432A (en) 1988-03-31
KR840009105A (ko) 1984-12-24
IE840831L (en) 1984-10-06
EP0124777A1 (de) 1984-11-14
CA1262906A (en) 1989-11-14
ATE23151T1 (de) 1986-11-15

Similar Documents

Publication Publication Date Title
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO164097C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater.
NO152129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO157146C (no) Analogifremgangsmaate ved fremstilling av terapeutisk, aktive derivater av morfolinyl-daunorbicin og morfolinyl-doksorubicin.
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO164168C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser.
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO171909C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO168107C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridiner
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO159528C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.